Related Experiment Video
Updated: Aug 11, 2026

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
Published on: April 16, 2012
CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors
M N Avice1, M Rubio, M Sergerie
1Allergy Research Laboratory, Research Center of CHUM, Notre-Dame Hospital, University of Montreal, and Department of Obstetrics and Gynecology, University of Montreal, Quebec, Canada.
Insights
CD47 ligation inhibits IL-12-driven Th1 cell development by reducing IL-2 production and IL-12 receptor expression. Restoring IL-2 levels corrects these effects, highlighting IL-2
Area of Science:
- Immunology
- Cell Biology
Background:
- CD47 (integrin-associated protein) regulates IL-12 production by monocytes and dendritic cells.
- Th1 cell development is crucial for adaptive immunity and is driven by IL-12.
Purpose of the Study:
- To investigate the role of CD47 ligation in IL-12-driven Th1 cell development.
- To elucidate the mechanisms by which CD47 influences Th1 differentiation.
Main Methods:
- Primary cultures of cord blood mononuclear cells were used.
- CD47 ligation was achieved using CD47 mAb, F(ab')(2) fragments, or the 4N1K peptide.
- Cytokine secretion, IFN-gamma production, IL-2 production, and IL-12Rbeta2 chain expression were analyzed.
Main Results:
- CD47 ligation inhibited IL-12-driven Th1 cell development, evidenced by reduced IFN-gamma production.
- CD47 engagement decreased IL-12-induced IL-2 production and IL-12Rbeta2 chain expression.
- Exogenous IL-2 supplementation corrected IL-12Rbeta2 expression and restored Th1 cell development.
- CD47 engagement did not alter Th1/Th2 phenotype or affect IL-4-induced Th2 development.
Conclusions:
- CD47 ligation inhibits Th1 cell development, partly through downregulation of IL-2 and IL-12Rbeta2.
- IL-2 plays a critical role in Th1 cell development.
- Simultaneous targeting of IL-2 and IL-12 may offer therapeutic benefits for Th1 autoimmune diseases.
Abstract:
The CD47 Ag, also named integrin-associated protein, was recently reported to regulate the production of IL-12 by human monocytes and dendritic cells. The present study shows that CD47 ligation by CD47 mAb in primary cultures of cord blood mononuclear cells inhibits IL-12-driven Th1 cell development, as revealed by the cytokine secretion profile at restimulation and IFN-gamma production at the single-cell level. F(ab')(2) fragments of CD47 mAb or the synthetic peptide 4N1K, corresponding to the CD47 binding site of thrombospondin, display the same activity. CD47 engagement does not change the phenotype of IL-12-primed cells from Th1 to Th2 or affect IL-4-induced Th2 cell development. Moreover, CD47 mAb inhibits IL-12- but not IL-4-induced IL-2 production as well as IFN-gamma in primary cultures, which was correlated with a decrease of the IL-12Rbeta2 chain expression. Inclusion of exogenous IL-2 at priming corrects IL-12R expression as well as the inhibition of Th1 cell development. The data thus underline the role of IL-2 in Th1 cell development and further suggest that targeting IL-2 and IL-12 simultaneously may have some therapeutic advantage in Th1 autoimmune diseases.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

